Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Steady-state kinetics of imipramine in patients.

Literature DB >> 413142

Steady-state kinetics of imipramine in patients.

L F Gram, I Sondergaard, J Christiansen, G O Petersen, P Bech, N Reisby, I Ibsen, J Ortmann, A Nagy, S J Dencker, O Jacobsen, O Krautwald.

Abstract

Entities: Chemical Species

Mesh：

Substances：
Imipramine
Desipramine

Year: 1977 PMID： 413142 DOI： 10.1007/bf00426573

Source DB: PubMed Journal: Psychopharmacology (Berl) ISSN： 0033-3158 Impact factor: 4.530

× No keyword cloud information.

21 in total

Review 1. Factors affecting drug metabolism.

Authors: J R Gillette
Journal: Ann N Y Acad Sci Date: 1971-07-06 Impact factor: 5.691

2. Imipramine: clinical effects and pharmacokinetic variability.

Authors: N Reisby; L F Gram; P Bech; A Nagy; G O Petersen; J Ortmann; I Ibsen; S J Dencker; O Jacobsen; O Krautwald; I Sondergaard; J Christiansen
Journal: Psychopharmacology (Berl) Date: 1977-11-15 Impact factor: 4.530

3. Influence of neuroleptics and benzodiazepines on metabolism of tricyclic antidepressants in man.

Authors: L F Gram; K Overo; L Kirk
Journal: Am J Psychiatry Date: 1974-08 Impact factor: 18.112

4. Pharmacokinetics of nortriptyline in man after single and multiple oral doses: the predictability of steady-state plasma concentrations from single-dose plasma-level data.

Authors: B Alexanderson
Journal: Eur J Clin Pharmacol Date: 1972-03 Impact factor: 2.953

5. Quantitative determination of imipramine and desipramine in human blood plasma by direct densitometry of thin-layer chromatograms.

Authors: A Nagy; L Treiber
Journal: J Pharm Pharmacol Date: 1973-08 Impact factor: 3.765

6. Plasma levels and antidepressive effect of imipramine.

Authors: L F Gram; N Reisby; I Ibsen; A Nagy; S J Dencker; P Bech; G O Petersen; J Christiansen
Journal: Clin Pharmacol Ther Date: 1976-03 Impact factor: 6.875

7. First-pass metabolism of imipramine in man.

Authors: L F Gram; J Christiansen
Journal: Clin Pharmacol Ther Date: 1975-05 Impact factor: 6.875

Review 8. Pharmacokinetics in the elderly.

Authors: J Crooks; K O'Malley; I H Stevenson
Journal: Clin Pharmacokinet Date: 1976 Impact factor: 6.447

9. Benzodiazepines and tricyclic antidepressant plasma levels.

Authors: G Silverman; R A Braithwaite
Journal: Br Med J Date: 1973-07-07

10. Intestinal absorption, demethylation, and enterohepatic circulation of imipramine.

Authors: H Dencker; S J Dencker; A Green; A Nagy
Journal: Clin Pharmacol Ther Date: 1976-05 Impact factor: 6.875

19 in total

1. A selective test for antidepressant treatments using rats bred for stress-induced reduction of motor activity in the swim test.

Authors: Charles Hutchison Keesor West; Jay Michael Weiss
Journal: Psychopharmacology (Berl) Date: 2005-09-29 Impact factor: 4.530

Steady-state kinetics of imipramine in patients.

Review 1. Factors affecting drug metabolism.

2. Imipramine: clinical effects and pharmacokinetic variability.

3. Influence of neuroleptics and benzodiazepines on metabolism of tricyclic antidepressants in man.

4. Pharmacokinetics of nortriptyline in man after single and multiple oral doses: the predictability of steady-state plasma concentrations from single-dose plasma-level data.

5. Quantitative determination of imipramine and desipramine in human blood plasma by direct densitometry of thin-layer chromatograms.

6. Plasma levels and antidepressive effect of imipramine.

7. First-pass metabolism of imipramine in man.

Review 8. Pharmacokinetics in the elderly.

9. Benzodiazepines and tricyclic antidepressant plasma levels.

10. Intestinal absorption, demethylation, and enterohepatic circulation of imipramine.

1. A selective test for antidepressant treatments using rats bred for stress-induced reduction of motor activity in the swim test.

Review 2. Plasma level monitoring of tricyclic antidepressant therapy.

3. Imipramine: clinical effects and pharmacokinetic variability.

4. Cardiovascular effects of amitriptyline in the treatment of elderly depressed patients.

Review 5. Pharmacokinetic optimisation of tricyclic antidepressant therapy.

6. Dose-dependent kinetics of imipramine in elderly patients.

7. Imipramine metabolism in relation to the sparteine and mephenytoin oxidation polymorphisms--a population study.

8. Steady-state concentrations of imipramine and its metabolites in relation to the sparteine/debrisoquine polymorphism.

Review 9. Steady-state kinetics of doxepin and imipramine in Saudi patients with interethnic comparison.

Review 10. Clinical pharmacokinetics of antidepressants in the elderly. Therapeutic implications.